Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers June 26, 2016
Pharmacy Choice - News - Generic Drugs - June 26, 2016

Pharmacy News

 Generic Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 70     Next >>     Go To Page:

6/25/16 - SC requests solicitor general to consider on biosimilars [National Iraqi News Agency (Iraq)]
Novartis has crossed all of the legal hurdles and launched its biosimilar of Neupogen, but its patent fight with Amgen was extended when the Swiss drugmaker asked the U.S. Supreme Court to get involved. In question are a number of issues that are key to Novartis ambitious biosimilars plans going forward; those issues will determine in whose pocket,
6/25/16 - United States : Impax to acquire genetic product portfolio for $586M [TendersInfo (India)]
Impax Laboratories, Inc. has announced that it entered definitive deals with Teva Pharmaceutical Industries Ltd. and associates of Allergan plc to acquire a wide range of generic products. The deals included solid oral, inhalable, injectable and topical dosage forms and the return of rights to Impax to the company's pending abbreviated new drug...
6/24/16 - EMA and FDA reinforce collaboration on patient engagement [Global Data Point]
We look forward to increasing our collaboration with FDA in this area in order to benefit from each other's experiences, and to advance patient involvement. " The currently existing EMA/ FDA clusters discuss issues related to biosimilars, medicines to treat cancer, orphan medicines, medicines for children, and pharmacovigilance, among other topics.
6/24/16 - Glenmark gets tentative nod for Olmesartan Medoxomil Tablets; stock falls 3% [India Infoline News Service]
Glenmark Pharmaceuticals Inc., USA has been granted tentative approval by the US Food& Drug Administration for Olmesartan Medoxomil Tablets, 5 mg, 20 mg and 40 mg, the generic version of Benicar Tablets of Daiichi Sankyo, Inc. Glenmark will market this product upon receiving final approval of its Olmesartan Medoxomil Tablets, 5 mg, 20 mg and 40 mg
6/24/16 - Mylan Launches Generic Avodart Capsules
HERTFORDSHIRE, England and PITTSBURGH, June 24, 2016/ PRNewswire/ Mylan N.V. today announced the U.S. launch of Dutasteride Capsules, 0.5 mg, the generic version of GlaxoSmithKline's Avodart Capsules. Dutasteride Capsules, 0.5 mg, had U.S. sales of approximately $297.2 million for the 12 months ending April 30, 2016, according to IMS Health.
6/24/16 - Natco Pharma ends 4% higher; gets FDA nod for Glycopyrrolate Tablets [India Infoline News Service]
Natoco Pharma ended 3.8% higher after the company clarified to the BSE regarding USFDA approval the company received for generic version of Glycopyrrolate Tablets. "We received from our US agent on 22nd June 2016 intimating the approval for generic version of Glycopyrrolate Tablets 1 mg and 2 mg from US FDA. We have not disclosed the said news to a
6/24/16 - Recent Studies from University of Maryland Add New Data to Social and Administrative Pharmacy (The Trans-Pacific Partnership and pharmaceutical...
The Trans-Pacific Partnership is the most recent multi-national agreement under considerations that may have profound implications in developed and developing countries in the Pacific Rim. " Our news journalists obtained a quote from the research from the University of Maryland, "As in the case of other trade arrangements, the TPP negotiations are
6/24/16 - Research Conducted at University of Occupational and Environmental Health Has Provided New Information about Rheumatology (The changing landscape of...
Research Conducted at University of Occupational and Environmental Health Has Provided New Information about Rheumatology. The news reporters obtained a quote from the research from the University of Occupational and Environmental Health, "Notably, rheumatologists will be at the forefront of the use of biosimilar monoclonal antibodies/soluble...
6/23/16 - Allergan Announces FDA Approval of Supplemental New Drug Application (sNDA) for AVYCAZ (ceftazidime and avibactam)
Allergan plc, a leading global pharmaceutical company, today announced the U.S. Food and Drug Administration has approved the company's supplemental New Drug Application to update the label for AVYCAZ with clinical data from a Phase 3 trial evaluating the safety and efficacy of AVYCAZ, in combination with metronidazole, for the treatment of co
6/23/16 - Antares Pharma Announces Settlement of Patent Litigation for Key Alliance Business Product
Antares Pharma, Inc. today announced that Teva Pharmaceuticals USA, Inc. has settled the patent litigation with AstraZeneca Pharmaceuticals LP, AstraZeneca AB and Amylin Pharmaceuticals, LLC relating to AstraZeneca s US Patent Nos. 6,858,576, 6,872,700, 6,956,026, 7,297,761, 6,902,744, 7,521,423, and 7,741,269 and AstraZeneca s BYETTA , a
6/23/16 - Global Hormone Replacement Therapy (HRT) Industry
The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America, and Rest of World. The report profiles 40 companies including many key and niche players such as- Abbott Laboratories AbbVie, Inc. Allergan plc Bayer Pharma AG Hisamitsu Pharmaceutical Co., Inc. Download the full report:...
6/23/16 - Healthcare Global Market Analytics Report 2016, Including: Healthcare Services, Pharmaceutical, Medical Equipment
Healthcare Global Market Analytics provides strategists, marketers& senior management with the critical information to assess the global healthcare sector.. The total value of the healthcare sector globally in 2015 was around $8500 bn. The dominance of generics post the loss of drug patents has negatively impacted the growth of the overall market b
6/23/16 - Natco Pharma gains on USFDA nod for generic Glycopyrrolate tablets [Tripoli Post, The (Libya)]
Natco Pharma was trading higher by 4% to Rs 552, extending its Wednesdays 6% rally on the BSE, after the company announced that it has received US Food and Drug Administration for generic version of Glycopyrrolate tablets. We received from our US agent on 22nd June 2016 intimating the approval for generic version of Glycopyrrolate Tablets 1 mg and
6/23/16 - New Review of Biosimilars in Oncology
Andrew D Zelenetz, Oncology& Hematology Review, 2016; 12: 22-8 http://doi.org/10. 17925/ OHR.2016.12.01.22. Published recently in Oncology& Hematology Review, the peer-reviewed journal from touchONCOLOGY, Andrew D Zelenetz, discusses the fact that the escalating cost of cancer care is placing an increasing burden on healthcare systems worldwide, la
6/23/16 - Pharmaceutical Excipients (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical) Market 2016 - Global Forecast to 2021
Dublin- Research and Markets has announced the addition of the "Pharmaceutical Excipients Market by Type, Functionality, Formulation- Global Forecast to 2021" report to their offering. The global pharmaceutical excipients market is projected to reach USD 8.1 Billion in 2021 at a CAGR of 6.1% in the forecast period 2016 to 2021.. Emerging markets su
6/23/16 - Pharmaceutical Excipients (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical) Market 2016 - Global Forecast to 2021 - Research and Markets
Research and Markets has announced the addition of the "Pharmaceutical Excipients Market by Type, Functionality, Formulation- Global Forecast to 2021" report to their offering. The global pharmaceutical excipients market is projected to reach USD 8.1 Billion in 2021 at a CAGR of 6.1% in the forecast period 2016 to 2021.. Emerging markets such as In
6/23/16 - Teva Settles Patent Litigation with AstraZeneca Allowing Teva to Commercialize Its Generic Version of Byetta (Exenatide Injection) in the United States
Teva Pharmaceuticals USA, Inc., today announced that they have settled the patent litigation with AstraZeneca Pharmaceuticals LP, AstraZeneca AB and Amylin Pharmaceuticals, LLC relating to AstraZeneca s US Patent Nos. 6,858,576, 6,872,700, 6,956,026, 7,297,761, 6,902,744, 7,521,423, and 7,741,269 and AstraZeneca s BYETTA , and entered into
6/23/16 - Vietnam Phamaceutical Report Q2/2016 Market Report; Launched via MarketResearchReports.com
Market Research Reports, Inc. has announced the addition of Vietnam Phamaceutical Report Q2/2016 research report to their website www.MarketResearchReports.comLewes, DE 06/23/2016 With 178 drug manufacturers Vietnam pharmaceutical products mostly focus on simple dosage forms and generic form with lower values and overlapping, and comple
6/22/16 - Alvotech Opens State-of-the-Art Biosimilar Facility in Iceland
By a News Reporter-Staff News Editor at Biotech Week Alvotech, a powerful player in the field of biopharmaceuticals, announces the opening of a new state-of-the-art facility, dedicated to the development and manufacturing of biosimilar monoclonal antibodies. The opening of this industry leading biologics manufacturing plant marks a significant...
6/22/16 - Key Pharma News Issue - Roche Willing To Pay Out For Innovation
Dublin- Research and Markets has announced the addition of the "Key Pharma News Issue 52" report to their offering. The current unmet medical need in influenza treatment creates a favourable commercial environment for MedImmune to enter. -Sanofi/ Merck To End European Joint Vaccines Operations- Teva Acquisition Of Allergan Generics Edges Closer Wit
6/22/16 - New Report Shares Details About Global Cancer Biosimilar Industry 2016 Consumption Outlook Illuminated by New Report
The Report Global Cancer Biosimilar Industry 2016 Market Research Report provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants.- MarketResearchReports.bizAlbany, NY 06/22/2016 The Global Cancer Biosimilar Industry 2016 Market Research Report is a professional and in-depth study
6/22/16 - Studies from C. D'Amore and Colleagues Provide New Data on Biotherapies and Biologicals (Switching Between Epoetins: A Practice in Support of...
Studies from C. D'Amore and Colleagues Provide New Data on Biotherapies and Biologicals. According to news originating from Perugia, Italy, by NewsRx correspondents, research stated, "The acceptability of switching between reference drugs and their biosimilars is often disputed. A retrospective drug utilization study was conducted in the Umbria reg
6/22/16 - Study Data from H.A. Cuello and Co-Authors Update Knowledge of Immunoglobulins (Comparability of Antibody-Mediated Cell Killing Activity Between a...
Study Data from H.A. Cuello and Co-Authors Update Knowledge of Immunoglobulins. By a News Reporter-Staff News Editor at Biotech Week Investigators publish new report on Immunology. According to news reporting from Buenos Aires, Argentina, by NewsRx journalists, research stated, "Biosimilars are described as biological products that resemble the s
6/22/16 - Upto 74% in brownfield pharma under automatic route [Seven Days (United Arab Emirates)]
The decision was taken at a meeting chaired by Prime Minister Narendra Modi. India is recognised as a major generic medicine hub of the world. In 2008, Japanese firm Daiichi Sankyo had bought out the countrys largest drug maker Ranbaxy for USD 4.6 billion.
6/21/16 - ACORDA THERAPEUTICS INC FILES (8-K) Disclosing Other Events
On June 20, 2016, the United States Court of Appeals for the Federal Circuit denied a request by Mylan Pharmaceuticals, Inc. and Mylan, Inc. for a rehearing of the Court's previous decision to uphold a lower court ruling that Acorda Therapeutics, Inc.' s Abbreviated New Drug Application litigation against Mylan can continue in the District Court of
Articles(s): 1 - 25 of 70     Next >>     Go To Page:


© 2016 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415